Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC.
Filings by Jill C. Milne span 2 companies, the busiest being Biocryst Pharmaceuticals Inc and Astria Therapeutics, Inc. Between 30 June 2015 and 11 June 2026, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 15 June 2026, the filings show a share grant in Biocryst Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations